A new framework for reverse cholesterol transport: Non-biliary contributions to reverse cholesterol transport

Ryan E. Temel, J. Mark Brown

Research output: Contribution to journalReview articlepeer-review

27 Scopus citations


Reduction of low-density lipoprotein-cholesterol through statin therapy has only modestly decreased coronary heart disease (CHD)-associated mortality in developed countries, which has prompted the search for alternative therapeutic strategies for CHD. Major efforts are now focused on therapies that augment high-density lipoprotein (HDL)-mediated reverse cholesterol transport (RCT), and ultimately increase the fecal disposal of cholesterol. The process of RCT has long been thought to simply involve HDL-mediated delivery of peripheral cholesterol to the liver for biliary excretion out of the body. However, recent studies have revealed a novel pathway for RCT that does not rely on biliary secretion. This nonbiliary pathway rather involves the direct excretion of cholesterol by the proximal small intestine. Compared to RCT therapies that augment biliary sterol loss, modulation of non-biliary fecal sterol loss through the intestine is a much more attractive therapeutic strategy, given that excessive biliary cholesterol secretion can promote gallstone formation. However, we are at an early stage in understanding the molecular mechanisms regulating the non-biliary pathway for RCT, and much additional work is required in order to effectively target this pathway for CHD prevention. The purpose of this review is to discuss our current understanding of biliary and nonbiliary contributions to RCT with particular emphasis on the possibility of targeting the intestine as an inducible cholesterol secretory organ.

Original languageEnglish
Pages (from-to)5946-5952
Number of pages7
JournalWorld Journal of Gastroenterology
Issue number47
StatePublished - 2010


  • Bile
  • Cholesterol
  • Intestine
  • Lipoprotein
  • Reverse cholesterol transport

ASJC Scopus subject areas

  • Gastroenterology


Dive into the research topics of 'A new framework for reverse cholesterol transport: Non-biliary contributions to reverse cholesterol transport'. Together they form a unique fingerprint.

Cite this